Kai Li

Kai Li

Auto-generated profile, based on publicly available information

Kai Li

Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2016 in OncoTargets and Therapy
Verified
Journal Article
Open access
PDF file
ZWZiwei Wang
Ziwei Wang
KLKai Li
Kai Li
XGXiaoguang Guo
Xiaoguang Guo
XLXiaofeng Li
Xiaofeng Li
YBYouquan Bu
Youquan Bu
YHYing Huang
Ying Huang
Increased aldehyde dehydrogenase 1 (ALDH1) activity has been determined to be present in the stem cells of several kinds of cancers including gastric cancer (GC). Nevertheless, which ones of ALDH1’s isoenzymes are leading to ALDH1 activity remains elusive. In this study, we examined the prognostic value and hazard ratio (HR) of individual ALDH1 isoenzymes in patients with GC using “The Kaplan–Meier plotter” database. mRNA high expression level of ALDH1A1 was not found to be significantly correlated with the overall survival (OS) of all patients with GC followed for 20 years, HR =0.86 (95% confidence interval [CI]: 0.7–1.05), P=0.13. mRNA high expression level of ALDH1A2 was also not significantly correlated with OS for all patients with GC, HR =1.13 (95% CI: 0.91–1.41), P=0.25. mRNA high expression level of ALDH1A3 was found to be significantly correlated with worsened OS in either intestinal-type patients, HR =2.24 (95% CI: 1.44–3.49), P=0.00026, or diffuse-type patients, HR =1.91 (95% CI: 1.02–3.59), P=0.04. Interestingly, mRNA high expression level of ALDH1B1 was found to be significantly correlated with better OS for all patients with GC, HR =0.66 (95% CI: 0.53–0.81), P=7.8e–05, and mRNA high expression level of ALDH1L1 was found to be significantly correlated with worsened OS for all patients with GC, HR =1.23 (95% CI: 1–1.51), P=0.048. Furthermore, our results also indicate that ALDH1A3 and ALDH1L1 are potential major contributors to the ALDH1 activity in GC, since mRNA high expression levels of ALDH1A3 and ALDH1L1 were found to be significantly correlated with worsened OS for all patients with GC. Based on our study, ALDH1A3 and ALDH1L1 are potential prognostic markers and therapeutic targets for patients with GC.

12 September 2023 in Mitochondrion
Verified
Journal Article
Closed access
JXJian Xue
Jian Xue
JZJinbao Zhang
Jinbao Zhang
JZJinru Zhang
Jinru Zhang
JLJunyi Liu
Junyi Liu
FWFen Wang
Fen Wang
CLChun-Feng Liu
Chun-Feng Liu

26 April 2013 in BMC Neurology
Verified
Journal Article
Open access
PDF file
KLKai Li
Kai Li
BTBei-Sha Tang
Bei-Sha Tang
JGJi-Feng Guo
Ji-Feng Guo
MLMing-Xing Lou
Ming-Xing Lou
ZLZhan-Yun Lv
Zhan-Yun Lv
XYXin-Xiang Yan
Xin-Xiang Yan
Background: Eukaryotic translation initiation factor 4-gamma 1 (EIF4G1) gene mutations have recently been reported in autosomal dominant, late-onset Parkinson’s disease (LOPD). We carried out genetic analysis to determine the prevalence of EIF4G1 variants in an ethnic Chinese population and to better understand the association between EIF4G1 and PD. Methods: We conducted a comprehensive genetic analysis of EIF4G1 in a cohort of 29 probands of autosomal dominant, LOPD families. Polymerase chain reaction (PCR) analysis and sequencing was carried out of the entire EIF4G1 exonic regions and exon-intron boundaries. Specific mutation and exonic variants were chosen for further sequencing in a case–control study including 503 sporadic PD and 508 healthy controls. Statistical significance was analyzed by the Chi-square test. Results: Our analysis revealed three exonic variants (rs2230571, rs13319149 and rs2178403) and eight intronic variants across the entire EIF4G1 gene. No reported mutations were detected in EIF4G1 exonic regions. The synonymous coding variant rs2230571 in exon 27 and the eight intronic variants were not used for further sequencing, but the specific mutation c.3614G > A (p.R1205H) and the two nonsynonymous variants (rs13319149 and rs2178403) were chosen for further analysis in a case–control study. None of the 503 sporadic PD or 508 healthy controls carried p.R1205H, and there was no statistical significance in rs2178403 genotype or allele frequencies in EIF4G1 between the PD cases and the healthy controls (p = 0.184 and p = 0.774, respectively; Chi-square test). The rs13319149 genotype in all PD cases and healthy controls was GG. Conclusions: Our data indicate that in an ethnic Chinese population, the pathogenic mutation p.R1205H in EIF4G1 is not common and that EIF4G1 exonic variants rs2178403 and rs13319149 are not associated with PD. EIF4G1 does not appear to be a frequent cause of PD in this ethnic Chinese population.

1 June 2023 in Parkinsonism & Related Disorders
Verified
Journal Article
Closed access
JXJian Xue
Jian Xue
DDDong-Xue Ding
Dong-Xue Ding
GXGuang-Yu Xu
Guang-Yu Xu
PWPu-Zhi Wang
Pu-Zhi Wang
YGYi-Lun Ge
Yi-Lun Ge
CLChun-Feng Liu
Chun-Feng Liu

27 July 2022 in Advanced Neurology
Verified
Journal Article
Open access
YGYi-Lun Ge
Yi-Lun Ge
PWPu-Zhi Wang
Pu-Zhi Wang
JYJia-Hui Yan
Jia-Hui Yan
WLWen Li
Wen Li
JZJin-Ru Zhang
Jin-Ru Zhang
CLChun-Feng Liu
Chun-Feng Liu
Hyposmia is one of the cardinal symptoms of Parkinson’s disease (PD), with a considerably high prevalence rate in PD individuals. However, some individuals still retain normal olfactory function. Recent studies have shown that genetic factors may play a role in such a phenomenon. This study aimed to explore the potential genetic factors underlying the variation of olfactory function among PD individuals. Two hundred and three Han Chinese individuals with PD were recruited into this study. All the individuals underwent detailed clinical assessment conducted by experienced neurologists. High-throughput sequencing was performed to identify gene variants associated with PD. TAAR5, OR6C70, and GBA were included in the association analysis. In our study, 85 out of 203 individuals (41.9%) reported normal olfaction, and the other 118 (58.1%) reported hyposmia. Genotype and allele logistic regression models were applied to association analysis. We did not find any significant association of TAAR5 and OR6C70 with hyposmia. However, we found that GBA rs762488 was associated with increased hyposmia risk (P = 0.036, OR = 3.05, 95% CI = 1.08–8.63), while GBA rs1800438 was associated with decreased hyposmia risk (P = 0.032, OR = 0.47, 95% CI = 0.24–0.94). In conclusion, this study revealed the association of GBA with hyposmia, indicating the genetic involvement in PD hyposmia variation. However, we did not replicate previous results (TAAR5 and OR6C70) in this study. Further studies with larger sample sizes in different populations are warranted.

11 December 2013 in BMC Neurology
Verified
Journal Article
Open access
PDF file
XLXin-Xin Liao
Xin-Xin Liao
ZZZi-Xiong Zhan
Zi-Xiong Zhan
YLYing-Ying Luo
Ying-Ying Luo
KLKai Li
Kai Li
JWJuling Wang
Juling Wang
LSLu Shen
Lu Shen
Background: Recent studies suggest that epigenetic factors may play an important role in the pathogenesis of Parkinson’s disease (PD). In our previous work, we sequenced the exomes of sixteen patients from eight Chinese PD families using whole exome sequencing technology, consequently three patients from different pedigrees were found sharing the variant c.1460C > T (rs150689919) in the coding region of the Tet methyl cytosine dioxygenase 1 (TET1) gene. Methods: In order to evaluate the possible association between sporadic PD and the single nucleotide polymorphism (SNP) rs150689919 in TET1, a case–control cohort study was conducted in 514 sporadic PD patients and 529 normal controls. Genotyping was determined by PCR and direct sequencing. Statistical significance was analyzed by the Chi-squared test. Results: There was no statistical significance in TET1 rs150689919 genotype or allele frequencies between the PD cases and healthy controls, even after being stratified by gender and age at onset. Conclusions: Our findings suggest that rs150689919 in TET1 may not be associated with PD in Chinese population. However, due to the limited data in this study, replication studies in larger sample and other populations are required.